How could gene therapy change the way we treat age-related macular degeneration?

IF 0.9 Q4 OPHTHALMOLOGY Expert Review of Ophthalmology Pub Date : 2022-11-02 DOI:10.1080/17469899.2022.2147927
Huma Khan, Hannah Khan, A. Aziz, Tyler M Ewing, A. Khanani
{"title":"How could gene therapy change the way we treat age-related macular degeneration?","authors":"Huma Khan, Hannah Khan, A. Aziz, Tyler M Ewing, A. Khanani","doi":"10.1080/17469899.2022.2147927","DOIUrl":null,"url":null,"abstract":"Age-related macular degeneration (AMD) is the leading cause of permanent vision loss in individuals over 50 years of age [1]. Advanced AMD can anatomically present as either neovascular (nAMD) or atrophic AMD. nAMD displays characteristic growth of abnormal vasculature that originates from the choroid or retina, resulting in macular neovascularization (MNV). MNV progression can lead to degeneration of photoreceptors, macular damage, and retinal pigment epithelium disruption [1]. If left untreated, MNV in nAMD can lead to leakage of fluid, lipid, and blood into the outer retina, resulting in irreversible vision loss [1]. Atrophic AMD can progress to geographic atrophy (GA), characterized by atrophy of choriocapillaris, retinal pigment epithelial cells, and macular photoreceptors [1].","PeriodicalId":39989,"journal":{"name":"Expert Review of Ophthalmology","volume":"17 1","pages":"371 - 374"},"PeriodicalIF":0.9000,"publicationDate":"2022-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17469899.2022.2147927","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Age-related macular degeneration (AMD) is the leading cause of permanent vision loss in individuals over 50 years of age [1]. Advanced AMD can anatomically present as either neovascular (nAMD) or atrophic AMD. nAMD displays characteristic growth of abnormal vasculature that originates from the choroid or retina, resulting in macular neovascularization (MNV). MNV progression can lead to degeneration of photoreceptors, macular damage, and retinal pigment epithelium disruption [1]. If left untreated, MNV in nAMD can lead to leakage of fluid, lipid, and blood into the outer retina, resulting in irreversible vision loss [1]. Atrophic AMD can progress to geographic atrophy (GA), characterized by atrophy of choriocapillaris, retinal pigment epithelial cells, and macular photoreceptors [1].
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基因疗法如何改变我们治疗老年性黄斑变性的方式?
年龄相关性黄斑变性(AMD)是50岁以上个体永久性视力丧失的主要原因[1]。晚期AMD在解剖学上可以表现为新生血管性AMD或萎缩性AMD。nAMD表现出源自脉络膜或视网膜的异常血管系统的特征性生长,导致黄斑新生血管形成(MNV)。MNV进展可导致光感受器退化、黄斑损伤和视网膜色素上皮破裂[1]。如果不及时治疗,nAMD中的MNV会导致液体、脂质和血液泄漏到视网膜外层,导致不可逆的视力丧失[1]。萎缩性AMD可发展为地理性萎缩(GA),其特征是绒毛膜毛细血管、视网膜色素上皮细胞和黄斑光感受器萎缩[1]。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Expert Review of Ophthalmology
Expert Review of Ophthalmology Health Professions-Optometry
CiteScore
1.40
自引率
0.00%
发文量
39
期刊介绍: The worldwide problem of visual impairment is set to increase, as we are seeing increased longevity in developed countries. This will produce a crisis in vision care unless concerted action is taken. The substantial value that ophthalmic interventions confer to patients with eye diseases has led to intense research efforts in this area in recent years, with corresponding improvements in treatment, ophthalmic instrumentation and surgical techniques. As a result, the future for ophthalmology holds great promise as further exciting and innovative developments unfold.
期刊最新文献
How Genome-Wide Association Studies Transform Care for Patients at Risk of Glaucoma. Systemic and Ocular Associations of Keratoconus. Spaceflight associated neuro-ocular syndrome (SANS): a systematic review, implications for the sans case definition Stem cell therapy in retinal diseases: current evidence Morphometric analysis of orbital CT scan in a Jordanian sample
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1